Article Text

This article has a correction. Please see:

PDF
Rheumatoid arthritis: correlation between rheumatoid factor levels and CA-125 tumour marker elevation
  1. Nicolas Tsavaris,
  2. Clio P Mavragani,
  3. Pikazis Dimitrios
  1. Oncology Unit, Department of Pathophysiology, Athens University School of Medicine, Laikon General Hospital, Athens, Greece
  1. Correspondence to:
    Dr N Tsavaris
    Oncology Unit, Department of Pathophysiology, Athens University School of Medicine, Laikon General Hospital, 115 27 Athens, Greece; tsavari1{at}otenet.gr

Statistics from Altmetric.com

Rheumatoid factors (RFs) are autoantibodies directed against the Fc portion of IgG. Tumour markers (eg, CA-125, CA-19-9) are tumour-expressed proteins that are usually measured in the serum by means of ELISA sandwich assays, in which murine monoclonal antibodies are used to capture the circulating antigen under investigation.1–3

Given the extensive homology between the Fc regions of murine and human IgG antibodies, it may not be unexpected that anecdotal reports have shown that tumour markers can be falsely increased in the presence of human antimouse antibodies or RFs.4–6 We systematically sought to determine whether patients with active RF-positive rheumatoid arthritis …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Correction
    BMJ Publishing Group Ltd and European League Against Rheumatism